Hind A. Alnajashi and Foziah Alshamrani, 2020. Progressive Multifocal Leukoencephalopathy Risk Mitigation: A Focus on Approved Immunomodulatory Drugs for Multiple Sclerosis Treatment. Journal of King Abdulaziz University: Medical Sciences. 27, 2 (Dec. 2020), 33–44. DOI:https://doi.org/10.4197/Med.27-2.6.